伽马影像引导下微创乳腺活检:初步临床经验
本研究回顾性分析了2011年4月至2015年10月间117例乳腺特异性伽马成像(BSGI/MBI)发现、超声和钼靶隐匿的可触及病灶,推荐行伽马影像引导下9G真空辅助活检。104例成功活检中32例(30.8%)病理异常,总体癌症检出率16.3%,阳性预测值癌症16.3%、癌症加高危病变30.8%。作者认为该技术是采样BSGI-MBI检出而无超声或钼靶对应病灶的可行方法。
要点
- 伽马影像引导活检对BSGI-MBI检出而超声钼靶隐匿的病灶可行,104例成功活检中癌症检出率16.3%。
- 104例活检中32例(30.8%)病理异常,包括9例浸润癌、6例导管原位癌和17例高危病变。
- 17例高危病变中3例小叶原位癌、5例不典型导管增生、2例不典型小叶增生、1例扁平上皮非典型、6例乳头状瘤。
核心结论
- 伽马影像引导活检是采样BSGI-MBI检出而无超声或钼靶对应病灶的可行方法,结果与MRI引导活检的报道相比有利。
研究设计与样本
- 回顾性研究,2011年4月至2015年10月间117例BSGI-MBI发现的非可触及、钼靶和超声隐匿病灶推荐行伽马影像引导活检,使用9G真空辅助装置并放置钛标记夹,评估病历和病理结果。
诊断标准与关键数值
- 117例推荐活检中104例成功、13例取消;104例中32例(30.8%)病理异常;32例中9例(28.1%)浸润癌、6例(18.8%)导管原位癌、17例(53.1%)高危病变;总体癌症检出率16.3%;阳性预测值癌症16.3%、癌症加高危病变30.8%。
临床应用与阅片要点
- 作者认为伽马影像引导活检是采样BSGI-MBI检出而无超声或钼靶对应病灶的可行方法。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
OBJECTIVE: The purpose of this study was to evaluate our initial experience with gamma imaging-guided vacuum-assisted breast biopsy in women with abnormal findings.
MATERIALS AND METHODS: A retrospective review of patients undergoing breast-specific gamma imaging (BSGI), also known as molecular breast imaging (MBI), between April 2011 and October 2015 found 117 nonpalpable mammographically and sonographically occult lesions for which gamma imaging-guided biopsies were recommended. Biopsy was performed with a 9-gauge vacuum-assisted device with subsequent placement of a titanium biopsy site marker. Medical records and pathologic findings were evaluated.
RESULTS: Of the 117 biopsies recommended, 104 were successful and 13 were canceled. Of the 104 performed biopsies, 32 (30.8%) had abnormal pathologic findings. Of those 32 biopsies, nine (28.1%) found invasive cancers, six (18.8%) found ductal carcinoma in situ (DCIS), and 17 (53.1%) found high-risk lesions. Of the 17 high-risk lesions, there were three (17.6%) lobular carcinomas in situ, five (29.4%) atypical ductal hyperplasias, two (11.8%) atypical lobular hyperplasias, one (5.9%) flat epithelial atypia, and six (35.3%) papillomas. Two cases of atypical ductal hyperplasia were upgraded to DCIS at surgery. The overall cancer detection rate for gamma imaging-guided biopsy was 16.3%. In this study, gamma imaging-guided biopsy had a positive predictive value of total successful biopsies of 16.3% for cancer and 30.8% for cancer and high-risk lesions.
CONCLUSION: Gamma imaging-guided biopsy is a viable approach to sampling BSGI-MBI-detected lesions without sonographic or mammographic correlate. Our results compare favorably to those reported for MRI-guided biopsy.
引用
- Brem RF, Mehta AK, Rapelyea JA, et al. Gamma Imaging-Guided Minimally Invasive Breast Biopsy: Initial Clinical Experience. AJR Am J Roentgenol. 2018. PMID: 29323551. doi:10.2214/AJR.17.18513
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。